Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-04-03

FDA Approved: MICAFUNGIN — Original Application (Glenmark Pharmaceuticals Inc., USA)

View source ↗

Summary

FDA approved Glenmark's original ANDA for generic micafungin for the treatment of invasive candidiasis, candidemia, esophageal candidiasis, and for prophylaxis …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Micafungin (micafungin)

Snippet

ORIG AP for MICAFUNGIN (MICAFUNGIN)